DOSSIER · 13F Holders · Q2 2026
LIMNW
LIMINATUS PHARMA INC.
22 institutions still hold LIMINATUS PHARMA INC. as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 53271X116·22 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
22 institutions reported LIMNW in Q2 2026. ARISTEIA CAPITAL, L.L.C. leads at 17.5% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 2
2 more holders available. Log in →